pteridines has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, T | 1 |
| Parker, R | 1 |
| Hawkins, E | 1 |
| Holkova, B | 1 |
| Yazbeck, V | 1 |
| Kolluri, A | 1 |
| Kmieciak, M | 1 |
| Rahmani, M | 1 |
| Grant, S | 1 |
| Vose, JM | 1 |
| Friedberg, JW | 1 |
| Waller, EK | 1 |
| Cheson, BD | 1 |
| Juvvigunta, V | 1 |
| Fritsch, H | 1 |
| Petit, C | 1 |
| Munzert, G | 1 |
| Younes, A | 1 |
| Dhondt, JL | 1 |
| Millot, F | 1 |
| Hayte, JM | 1 |
| Mazingue, F | 1 |
| Farriaux, JP | 1 |
1 trial available for pteridines and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.
Topics: Adult; Aged; Aged, 80 and over; Cell Cycle Proteins; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mi | 2013 |
2 other studies available for pteridines and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms.
Topics: Animals; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation | 2017 |
2,4-diamino-7-hydroxy-pteridines in biological fluids of patients on high-dose methotrexate.
Topics: Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant | 1993 |